Header Logo

Connection

Ebrahim Variava to Oxazoles

Back to Details
This is a "connection" page, showing publications Ebrahim Variava has written about Oxazoles.
Ebrahim Variava
Connection Strength
0,160
Oxazoles
  1. Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial. Lancet Respir Med. 2019 03; 7(3):249-259.
    View in: PubMed
    Score: 0,160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.